Andrew Mulato

Selective Intracellular Activation of a Novel Prodrug of the Human Immunodeficiency Virus Reverse Transcriptase Inhibitor Tenofovir Leads to Preferential Distribution and Accumulation in Lymphatic Tissue

William A. Lee, T. Cihlar, S. Swaminathan, 2005, Antimicrobial Agents and Chemotherapy.

Nonsteroidal anti-inflammatory drugs efficiently reduce the transport and cytotoxicity of adefovir mediated by the human renal organic anion transporter 1.

T. Cihlar, E. Ho, A. Mulato, 2000, The Journal of pharmacology and experimental therapeutics.

A highly potent long-acting small-molecule HIV-1 capsid inhibitor with efficacy in a humanized mouse model

A. Brass, W. Sundquist, Melanie H. Wong, 2019, Nature Medicine.

Identification of NK Cell Subpopulations That Differentiate HIV-Infected Subject Cohorts with Diverse Levels of Virus Control

G. Nolan, A. Arvey, G. Kukolj, 2019, Journal of Virology.

GS-8374, a Novel Phosphonate HIV Protease Inhibitor with Potent In Vitro Antiretroviral Activity, Low Metabolic Toxicity, and Favorable Resistance Profile

William A. Lee, N. Parkin, Luong K. Tsai, 2007 .

Suppression of HIV-1 protease inhibitor resistance by phosphonate-mediated solvent anchoring.

William A. Lee, M. Hatada, Xiaohong Liu, 2006, Journal of molecular biology.

Antiviral Activity of Bictegravir (GS-9883), a Novel Potent HIV-1 Integrase Strand Transfer Inhibitor with an Improved Resistance Profile

K. White, Helen Yu, G. Kukolj, 2016, Antimicrobial Agents and Chemotherapy.

Rapid In Vitro Evaluation of Antiretroviral Barrier to Resistance at Therapeutic Drug Levels

K. White, G. Stepan, S. Yant, 2016 .